SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IMMULOGIC
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
305 5 0 IMUL
Emcee:  Bhag Karamchandani Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
30 Bhag, The WSJ briefing book is accessible through the on-line Wall Street JournLyle Abramowitz-4/29/1996
29 Thanks. I did not see any reference in today's (29/4) WSJ print copy. For tBhag Karamchandani-4/29/1996
28 Trial results for ALLERVAX Cat released 4/26 Apparently, the market did not liLyle Abramowitz-4/27/1996
27 IMUL off more than $2- over a million shares traded. No news???Bhag Karamchandani-4/27/1996
26 Paul: Thanks. I guess it will be interesting to see what the Allervax results, Bhag Karamchandani-4/22/1996
25 IMUL's technology has wide applications, so the company is not confining itPaul Getman-4/22/1996
24 Thanks for the update. By the way does IMUL have non- allergy drugs in the pipeBhag Karamchandani-4/19/1996
23 Schering, a large pharmaceutical company in Germany, sold their shares in IMUL.Paul Getman-4/19/1996
22 Paul, there was additional news today that drove IMUL down. Apparently, ScheriLyle Abramowitz-4/9/1996
21 The rise in revenues was due to a milestone payment by HMR. Needless to say, thPaul Getman-4/3/1996
20 Is there anything that will give us a likely guess at how the Phase III trials Ira Vine-4/3/1996
19 There have been some positive developments since the mini-crash in March. FirstPaul Getman-4/2/1996
18 IMUL has been running pretty good these few days. Do you know why? Thanxanna-4/1/1996
17 To my knowledge, there are no other pure plays in allergies among biotechs. PaPaul Getman-3/27/1996
16 Paul: Do you know of any other bio-techs specializing in treating allergies? IBhag Karamchandani-3/25/1996
15 The absence of a partner won't affect the initial introduction of Allervax-Paul Getman-3/25/1996
14 Paul: Thanks for taking the time to outline your well thought out assessment ofBhag Karamchandani-3/25/1996
13 Call 617-466-6000 and ask for Susan Primrose in investor relations. She's vPaul Getman-3/23/1996
12 Hi Bhag, I always shy away from offering advice on particular stocks because ePaul Getman-3/23/1996
11 Hi Ira, The potential market for better allergy products is huge--in the high Paul Getman-3/23/1996
10 Paul, would you give me more info about IMUL. I've just called 1-508-475-0anna-3/21/1996
9 To all, IMUL phone# 617-555-1212.anna-3/21/1996
8 You appear to be knowledgeable about IMUL. I saw their press release - it certaBhag Karamchandani-3/20/1996
7 I believe their former partner was Hoecht or Rhone ( I am not exactly sure). IBhag Karamchandani-3/18/1996
6 Thanks for the correction; my short-term memory must be getting rusty. I have Ira Vine-3/17/1996
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):